Lopresor 25mg Tablet contains Metoprolol Tartrate, a cardioselective beta-1 adrenergic receptor blocker used primarily in the management of hypertension, angina pectoris, and heart failure. By selectively inhibiting beta-1 receptors in the heart, Lopresor reduces heart rate, myocardial contractility, and cardiac output, thereby lowering blood pressure and decreasing myocardial oxygen demand. This therapeutic effect helps prevent angina attacks and improves survival following myocardial infarction. Lopresor is also employed in the treatment of certain arrhythmias and for the management of stable chronic heart failure as part of a comprehensive treatment regimen. The 25mg dosage allows for careful titration based on patient response and tolerability. Metoprolol Tartrate is administered orally and exhibits a relatively short half-life, necessitating multiple daily doses for sustained effect. Common side effects may include fatigue, dizziness, bradycardia, and gastrointestinal disturbances. Caution is advised in patients with asthma, diabetes, or peripheral vascular disease due to potential exacerbation of symptoms. Lopresor should be used under medical supervision with regular monitoring of blood pressure, heart rate, and clinical status to optimize therapeutic outcomes and minimize adverse effects.